HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cutaneous porphyria in a neonate with tyrosinaemia type 1.

AbstractUNLABELLED:
A term infant born to consanguineous parents presented at birth with hypoglycaemia, thrombocytopenia, coagulopathy and hyperbilirubinaemia associated with polycythaemia due to delayed cord clamping. Despite phototherapy and correction of polycythaemia by partial exchange transfusion, coagulopathy, hypoglycaemia and conjugated hyperbilirubinaemia persisted, suggesting hepatic failure. Metabolic work-up led to the diagnosis of tyrosinaemia type 1 on day 4. Two--(2-nitro-4-trifluoromethylbenzoyl)--1,3 cyclohexanedione (NTBC) treatment, started on day 5, resulted in progressive clinical improvement and unambiguous biochemical response. Severe skin purpuric lesions occurred in areas exposed to phototherapy. These resolved slowly after its discontinuation. Urine analysis sampled just before and 6 days after starting NTBC treatment showed high levels of type 1 coproporphyrin isomers. Such findings do not seem directly related to tyrosinaemia type 1 where succinylacetone inhibits delta-aminolevulinic acid (delta-ALA) dehydratase and where the accumulation of delta-ALA results in neurotoxicity without photosensitivity.
CONCLUSION:
We describe a cutaneous form of porphyria in a neonate presenting with severe liver failure due to tyrosinaemia type 1. This porphyria is tentatively attributed to a secondary accumulation of coproporphyrins due to cholestasis, as reported in the bronze baby syndrome and recently described in neonates with purpuric phototherapy-induced eruption, rather than to a primary defect of porphyrin metabolism. The hypothesis of a direct effect of tyrosinaemia type 1 on porphyrin excretion is also discussed.
AuthorsS Vanden Eijnden, D Blum, A Clercx, P Goyens, C De Laet, E Vamos
JournalEuropean journal of pediatrics (Eur J Pediatr) Vol. 159 Issue 7 Pg. 503-6 (Jul 2000) ISSN: 0340-6199 [Print] Germany
PMID10923223 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Coproporphyrins
  • Cyclohexanones
  • Enzyme Inhibitors
  • Nitrobenzoates
  • nitisinone
Topics
  • Combined Modality Therapy
  • Consanguinity
  • Coproporphyrins (urine)
  • Cyclohexanones (therapeutic use)
  • Enzyme Inhibitors (therapeutic use)
  • Humans
  • Infant, Newborn
  • Liver Failure (diagnosis, genetics, therapy)
  • Male
  • Nitrobenzoates (therapeutic use)
  • Photosensitivity Disorders (diagnosis, genetics, therapy)
  • Phototherapy
  • Porphyria Cutanea Tarda (diagnosis, genetics, therapy)
  • Tyrosinemias (diagnosis, genetics, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: